Related Experiment Video
Updated: Nov 3, 2025

06:19
Author Spotlight: Advancing SERS Technology: Au@Carbon Dot Nanoprobes for Label-Free Analysis and Imaging
Published on: June 9, 2023
1.6K
Digital SERS bioanalysis of single-enzyme biomarkers
Jun Ando1, Kazue Murai1, Tomoe Michiyuki1
1Molecular Physiology Laboratory, Pioneering Research Institute, RIKEN, Wako, Saitama 351-0198, Japan.
Summary
A new digital bioanalysis platform uses surface-enhanced Raman scattering for sensitive, multiplexed detection of enzyme biomarkers. This method offers enhanced selectivity and precision for complex biological samples, advancing diagnostic capabilities.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Spectroscopy
Background:
- Digital bioanalysis offers single-molecule detection but conventional fluorescence methods have limitations in molecular selectivity and multiplexing.
- Existing techniques struggle to simultaneously analyze multiple targets and differentiate closely related biomolecules.
Purpose of the Study:
- To develop a novel digital bioanalysis platform using surface-enhanced Raman scattering (SERS) for highly selective and multiplexed detection of enzyme biomarkers.
- To overcome the limitations of fluorescence-based methods in terms of molecular selectivity and simultaneous multi-target analysis.
Main Methods:
- Development of a digital bioanalysis platform integrating SERS spectroscopy with microchamber arrays functionalized with silver nanoparticles.
- Utilizing SERS for million-fold signal amplification of single-enzyme reaction products.
- Leveraging distinct Raman spectral signatures for precise digital counting and multiplexed quantification.
Main Results:
- The SERS-based platform achieved a million-fold signal amplification, enabling precise digital counting of enzyme biomarkers.
- Demonstrated high molecular selectivity and multiplexing capability by detecting and distinguishing acetylcholinesterase (AChE) and butyrylcholinesterase.
- Achieved femtomolar-level sensitivity for multiplexed biomarker quantification and successfully quantified AChE in human cerebrospinal fluid within 8.5 minutes.
Conclusions:
- The developed SERS digital bioanalysis platform provides enhanced molecular selectivity and multiplexing capability, serving as a valuable alternative to fluorescence-based methods.
- The platform demonstrates significant potential for clinical diagnostics, particularly in differentiating dementia types through precise enzyme level quantification in complex biological samples.
- This study expands the scope of digital bioanalysis, enabling high-precision quantification of multiple biomarkers in complex matrices.

